McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
597.17
+12.79 (2.19%)
Jan 23, 2025, 4:00 PM EST - Market closed

McKesson Revenue

McKesson had revenue of $93.65B in the quarter ending September 30, 2024, with 21.29% growth. This brings the company's revenue in the last twelve months to $330.19B, up 13.43% year-over-year. In the fiscal year ending March 31, 2024, McKesson had annual revenue of $308.95B with 11.65% growth.

Revenue (ttm)
$330.19B
Revenue Growth
+13.43%
P/S Ratio
0.23
Revenue / Employee
$6,474,255
Employees
51,000
Market Cap
75.80B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024308.95B32.24B11.65%
Mar 31, 2023276.71B12.75B4.83%
Mar 31, 2022263.97B25.74B10.80%
Mar 31, 2021238.23B7.18B3.11%
Mar 31, 2020231.05B16.73B7.81%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings